Botox and Xeomin is a brand name for botulinum toxin-type A, a neurotoxin that blocks messages between muscles and nerves that control them.
The FDA has approved the use of Botox and Xeomin to treat facial dystonias (spasms), strabismus (crossed eyes), and to temporarily soften facial rhytids (wrinkles) between the eyebrows and crows feet. While the FDA has not approved injections to improve the appearance of wrinkles in other areas of the face, physicians may perform these “off label” procedures.
The temporary effects of Botox/Xeomin become apparent 2-5 days after the injection is given and generally last 4-6 months. There are alternatives to Botox/Xeomin which include medications, surgery on facial nerves and muscles or no treatment.
Side Effects and Complications include but are not limited to:
Under-correction (not enough effect) or overcorrection (too much effect)
Facial asymmetry (one side looks different than the other)
Droopy eyelid, double vision, inability to close eye, drinking from a straw
Permanent loss of muscle tone with repeated injection
Flu-like symptoms or respiratory infection, nausea or headaches
Development of antibodies
Derived albumin and carries a theoretic risk of virus transmission.
There have been no reports of disease transmission.
You should not have Botox/Xeomin if you are allergic to albumin, pregnant, nursing, have an infection, or have Eaton-Lambert Syndrome, Lou Gehrig’s disease, or myasthenia gravis. No guarantees regarding results have been made.
The potential benefits have been explained of Botox/Xeoming along with alternative methods.